If you're thinking about testosterone therapy but still want children on your own timeline, the good news is that this is a known, well-studied tradeoff — not a guessing game. The smart move is to understand the mechanism before you start, because the order in which you do things matters.
The myth worth correcting first
A common belief is that low energy automatically means "you need testosterone shots." The more accurate picture: testosterone is one part of a feedback loop, and the loop is what determines fertility. Your brain's hypothalamus and pituitary release signals — gonadotropin-releasing hormone (GnRH), then luteinizing hormone (LH) and follicle-stimulating hormone (FSH) — that tell the testes to make both testosterone *and* sperm [1]. LH drives testosterone production; FSH drives sperm production. Intratesticular testosterone (the concentration inside the testes) needs to be far higher than blood levels for normal sperm production [2].
Here's the catch that worries founders and athletes alike: when you add testosterone from outside the body, the brain senses there's plenty and dials down LH and FSH. Less LH and FSH means the testes get less stimulation, intratesticular testosterone drops, and sperm production can fall — sometimes to zero. This is well-documented enough that exogenous testosterone has been studied as a *male contraceptive* [3]. That is the honest fertility tradeoff, stated plainly.
Source: [1] Physiology, Gonadotropin-Releasing Hormone (StatPearls, NIH NCBI Bookshelf), [2] Hsieh TC, et al. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy. J Urol.
How much suppression — and is it reversible?
For most men, the suppression of sperm production from testosterone therapy is reversible after stopping, but recovery takes time and isn't guaranteed for everyone. Pooled data on hormonal male contraception found that the large majority of men recovered sperm counts to a defined threshold after discontinuation, with recovery measured in months, not weeks [3]. The variables include how long therapy lasted, baseline fertility, age, and individual biology. "Probably reversible, eventually" is a very different planning assumption than "reversible on my schedule" — which is exactly why providers ask about family timing *before* anything starts.
Why providers weigh fertility-sparing approaches
This is where the conversation gets more interesting than "shots or nothing." When the goal is to address symptoms of low testosterone *while preserving the brain-to-testes signal*, an independent provider may consider approaches that work with the feedback loop rather than overriding it.
One studied molecule is clomiphene and its purified isomer enclomiphene. These are selective estrogen receptor modulators (SERMs). By blocking estrogen feedback at the hypothalamus and pituitary, they can prompt the body to release *more* LH and FSH — which in turn stimulates the testes' own testosterone and sperm production, rather than replacing it [4][5]. Because the signal stays "on," this category is of particular interest to men who want to keep fertility on the table. Clomiphene is FDA-approved for female infertility; its use for male hypogonadism is off-label, and any decision belongs to a licensed provider who has reviewed your full picture [4].
Other tools in the broader fertility-aware toolkit that providers and the medical literature discuss include human chorionic gonadotropin (hCG), which mimics LH to maintain intratesticular testosterone, and is sometimes studied alongside testosterone specifically to help preserve sperm production [2][6]. None of this is a recommendation — it's the menu a provider actually evaluates, and what's appropriate (if anything) depends entirely on you.
> Some of these molecules may be available as compounded preparations. Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.
The biomarkers reviewed before any decision
A single "low normal" reading from urgent care is genuinely not enough to act on — and a thorough provider won't treat it that way. The Endocrine Society guideline recommends diagnosing low testosterone only with symptoms plus unequivocally low morning testosterone measured on at least two separate occasions, because testosterone is highest in the morning and fluctuates day to day [7].
A fertility-aware workup typically looks well beyond a single total testosterone number:
- Total and free testosterone, drawn in the morning, repeated to confirm [7].
- LH and FSH — these reveal whether the problem is the testes (primary) or the brain's signaling (secondary), which changes the whole approach [7].
- SHBG (sex hormone–binding globulin) — affects how much testosterone is actually free and active [7].
- Estradiol — relevant because the feedback loop runs partly through estrogen.
- Prolactin — elevated levels can suppress the axis and point to another cause [7].
- Semen analysis and a fertility conversation — if children are a priority, baseline sperm parameters matter before any therapy, not after.
- Hematocrit and PSA as part of standard testosterone-therapy safety monitoring, since therapy can raise red blood cell counts [7].
The point of this panel isn't paperwork. It's that LH and FSH, paired with confirmed testosterone and a semen baseline, tell a provider whether a fertility-sparing path is even mechanistically sensible for you — or whether the answer is something else entirely.
confirmatory measurements · marker = Endocrine Society guideline
What this means if kids are non-negotiable
If preserving fertility is a hard line right now, the practical takeaways are straightforward. First, get confirmed morning labs with LH/FSH, not a single drive-by reading. Second, have the fertility conversation *up front* — including a baseline semen analysis if relevant — because options narrow once standard testosterone has already suppressed the axis. Third, understand that fertility-sparing approaches exist precisely because the brain-to-testes signal can be supported rather than shut down. Whether any of them fit you is a decision for an independent licensed provider, and a prescription is never guaranteed.
This article is educational and is not medical advice, diagnosis, or a recommendation to take any specific medication. Talk with a licensed provider about your individual situation.
Where Velri fits
Velri is a technology and coordination company — it does not provide medical care. What Velri can do is reduce the friction in getting a real answer: coordinating the lab work described above, connecting you with an independent, licensed provider who reviews your biomarkers and your goals (including fertility), and — *only if* that provider determines it's appropriate and writes a prescription — coordinating with an independent licensed pharmacy. Care decisions are made by the independent provider group, not by Velri, and no outcome or prescription is promised. If keeping the door open to children matters to you, that's exactly the kind of goal worth putting in front of a provider before anything begins.
